SEC ownership of EQUINIX INC

Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001101239.

Comparable stake leader

VANGUARD CAPITAL MANAGEMENT LLC

Disclosed value leader

BlackRock, Inc.

Comparable rows

50/50

Latest evidence

21 May 2026

Ownership snapshot CIK-linked ownership evidence from parsed SEC filings. 2 signals
Latest 13D/G holder
VANGUARD CAPITAL MANAGEMENT LLC
Latest parsed ownership date
21 May 2026
Issuer Names, identifiers, and filing context for this profile. 2 identity fields
Issuer CIK
0001101239
Issuer location
Redwood City, CA

Ownership snapshot

Top shareholders of EQUINIX INC (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
VANGUARD CAPITAL MANAGEME...
Disclosed value leader
BlackRock, Inc.
Comparable rows
50/50
Latest evidence
21 May 2026
13D/G 13F 3/4/5 Lead comparable stake: 7.6% 13D/G row: VANGUARD CAPITAL MANAGEMENT LLC Showing 1-8 of 50 holder rows.

Quick read

VANGUARD CAPITAL MANAGEMENT LLC leads the comparable SEC ownership view at 7.6%.

50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens VANGUARD CAPITAL MANAGEMENT LLC's linked filing trail.
Comparable ownership Top 5
VANGUARD CAPITAL MANAGEMENT LLC 7.6%
Keith D. Taylor 0.03%
Brandi Galvin Morandi 0.01%
Simon Miller 0.01%
Charles J. Meyers 0.01%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-8 of 50 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
VANGUARD CAPITAL MANAGEMENT LLC
13D/G 13F
Vanguard Capital Management · Company
7.6%
$8,127,531,859
7,426,880 shares
$0 31 Mar 2026
Keith D. Taylor
3/4/5
Chief Financial Officer
0.03%
$25,555,446
26,587 shares
-$6,555,486 11 Mar 2026
Brandi Galvin Morandi
3/4/5
Chief People Officer
0.01%
$9,663,652
9,858 shares
-$4,237,816 06 May 2026
Simon Miller
3/4/5
Chief Accounting Officer
0.01%
$7,379,582
7,615 shares
-$1,111,820 11 Mar 2026
Charles J. Meyers
3/4/5
Director, Executive Chairman
0.01%
$8,028,186
7,370 shares
-$15,728,775 06 May 2026
Rebecca J. Kujawa
3/4/5
Director
0%
$166,640
170 shares
21 May 2026
BlackRock, Inc.
13F
Company
13F
11%
$10,911,608,116
11,131,568 shares
31 Mar 2026
STATE STREET CORP
13F
Company
13F
6.2%
$5,958,286,895
6,078,396 shares
31 Mar 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Forms 3/4/5 flow

Insider trading overview

Net insider flow leans to selling over the last 12 months. Net value: -$53,180,648.

Buys
$0
Insiders: 0
Sells
$53,180,648
Insiders: 10
Net
-$53,180,648
Shares: -58,280
Window
Last 12 months
4 rolling buckets
Buy value Sell value
Shares: 0 Shares: 58,280
Window (months) Buy shares Sell shares Buy value Sell value Net value
0-3 0 16,102 $0 $16,746,962 -$16,746,962
3-6 0 32,374 $0 $28,972,923 -$28,972,923
6-9 0 9,108 $0 $6,929,640 -$6,929,640
9-12 0 695 $0 $531,123 -$531,123

Reporting owners

Insider holders from Forms 3/4/5

Showing 1-20 of 28 reporting-owner rows connected to EQUINIX INC. Open a relationship link for the CIK-to-CIK filing trail.

Rows
28
Largest Forms 3/4/5 holder
Gary Hromadko
Net 12M change
-$53,180,648
Latest report
01 Jun 2026
Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
Gary Hromadko Director $139,867,504 Median 21 May 2026
Adaire Fox-Martin CEO and President, Director $30,584,105 -$12,361,557 -29% Mixed 01 Jun 2026
Keith D. Taylor Chief Financial Officer $25,555,446 -$6,555,486 -20% Filing P/S 11 Mar 2026
Christopher B. Paisley Director $18,022,692 -$324,858 -1.8% Median 21 May 2026
Michael Earl Campbell Chief Sales Officer $14,188,634 Mixed 06 Sep 2024
Karl Strohmeyer Chief Customer & Rev Officer $13,290,606 Mixed 05 May 2023
Jonathan Lin Chief Business Officer $11,679,466 -$2,632,807 -18% Filing P/S 01 Jun 2026
Sara Jane Baack Chief Product Officer $11,096,596 Mixed 01 Sep 2021
Brandi Galvin Morandi Chief People Officer $9,663,652 -$4,237,816 -30% Median 06 May 2026
Charles J. Meyers Director, Executive Chairman $8,028,186 -$15,728,775 -66% Filing P/S 06 May 2026
Peter van Camp Executive Chairman, Director $7,937,027 Mixed 06 Mar 2024
Simon Miller Chief Accounting Officer $7,379,582 -$1,111,820 -13% Filing P/S 11 Mar 2026
Raouf Abdel EVP, Global Operations $6,352,339 -$6,584,643 -51% Filing P/S 01 Jun 2026
Thomas A. Bartlett Director $4,889,198 Mixed 18 Jun 2021
Kurt Pletcher Chief Legal Officer $4,767,752 -$2,438,393 -34% Mixed 01 Jun 2026
Scott Crenshaw EVP, GM Digital Services $4,355,317 Mixed 06 Sep 2024
Meredith Williamson Chief Customer & Rev Officer $3,377,088 Mixed 03 Sep 2024
Michael Shane Paladin Chief Customer & Rev Officer $2,376,696 -$1,204,493 -34% Filing P/S 11 Mar 2026
Nanci Caldwell Director $1,863,870 Mixed 13 May 2026
Thomas S. Olinger Director $1,093,947 Median 21 May 2026

Recent insider transactions for EQUINIX INC

Showing up to 300 recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % SEC-reported value SEC-reported price Shares Shares owned Date Ownership
Kurt Pletcher EQIX Common Stock Sale -1.85% $84,025 $1060.25 -79.25 4,212 02 Jun 2026 Direct
Jonathan Lin EQIX Common Stock Sale -1.36% $159,326 $1060.41 -150 10,911 02 Jun 2026 Direct
Raouf Abdel EQIX Common Stock Sale -2.6% $167,806 $1060.38 -158 5,934 02 Jun 2026 Direct
Adaire Fox-Martin EQIX Common Stock Sale -11.6% $3,102,612 $1057.11 -2,935 22,284 02 Jun 2026 Direct
Kurt Pletcher EQIX Common Stock Options Exercise 4.43% 182 4,291 01 Jun 2026 Direct
Kurt Pletcher EQIX Restricted Stock Unit Options Exercise -25% -182 546 01 Jun 2026 Direct
Jonathan Lin EQIX Common Stock Options Exercise 2.53% 273 11,061 01 Jun 2026 Direct
Jonathan Lin EQIX Restricted Stock Unit Options Exercise -25% -273 819 01 Jun 2026 Direct
Raouf Abdel EQIX Common Stock Options Exercise 6.35% 364 6,092 01 Jun 2026 Direct
Raouf Abdel EQIX Restricted Stock Unit Options Exercise -25% -364 1,092 01 Jun 2026 Direct
Adaire Fox-Martin EQIX Common Stock Options Exercise 28.8% 5,645 25,219 01 Jun 2026 Direct
Adaire Fox-Martin EQIX Restricted Stock Unit Options Exercise -100% -5,645 0 01 Jun 2026 Direct
Raouf Abdel EQIX Common Stock Sale -26.3% $2,210,279 $1083.47 -2,040 5,728 22 May 2026 Direct
Rebecca J. Kujawa EQIX Common Stock Options Exercise 170 170 21 May 2026 Direct
Rebecca J. Kujawa EQIX Restricted Stock Unit Options Exercise -100% -170 0 21 May 2026 Direct
Gary Hromadko EQIX Common Stock Options Exercise 0.21% 302 142,687 21 May 2026 Direct
Gary Hromadko EQIX Restricted Stock Units Options Exercise -100% -302 0 21 May 2026 Direct
Yanbing Li EQIX Common Stock Options Exercise 255 255 21 May 2026 Direct
Yanbing Li EQIX Restricted Stock Units Options Exercise -100% -255 0 21 May 2026 Direct
Thomas S. Olinger EQIX Common Stock Options Exercise 37.1% 302 1,116 21 May 2026 Direct
Thomas S. Olinger EQIX Restricted Stock Units Options Exercise -100% -302 0 21 May 2026 Direct
Christopher B. Paisley EQIX Common Stock Options Exercise 1.72% 302 17,859 21 May 2026 Paisley Family Trust
Christopher B. Paisley EQIX Restricted Stock Units Options Exercise -100% -302 0 21 May 2026 Direct
Fidelma Russo EQIX Common Stock Options Exercise 89.4% 302 640 21 May 2026 Direct
Fidelma Russo EQIX Restricted Stock Units Options Exercise -100% -302 0 21 May 2026 Direct
Christopher B. Paisley EQIX Common Stock Sale -0.71% $132,536 $1060.29 -125 17,557 18 May 2026 Paisley Family Trust
Yanbing Li EQIX Restricted Stock Unit Award 241 241 13 May 2026 Direct
Fidelma Russo EQIX Restricted Stock Unit Award 241 241 13 May 2026 Direct
Sandra L. Rivera EQIX Restricted Stock Unit Award 241 241 13 May 2026 Direct
Gary Hromadko EQIX Restricted Stock Unit Award 241 241 13 May 2026 Direct
Rebecca J. Kujawa EQIX Restricted Stock Unit Award 241 241 13 May 2026 Direct
Thomas S. Olinger EQIX Restricted Stock Unit Award 241 241 13 May 2026 Direct
Christopher B. Paisley EQIX Restricted Stock Unit Award 241 241 13 May 2026 Direct
Nanci Caldwell EQIX Restricted Stock Unit Award 241 241 13 May 2026 Direct
Charles J. Meyers EQIX Common Stock Sale -41.5% $5,669,216 $1085.23 -5,224 7,370 06 May 2026 Direct
Brandi Galvin Morandi EQIX Common Stock Gift -1.12% -112 9,858 06 May 2026 Direct
Brandi Galvin Morandi EQIX Common Stock Sale -4.08% $432,480 $1020.00 -424 9,970 08 Apr 2026 Direct
Olivier Leonetti EQIX Restricted Stock Unit Award 9,000 5,422 16 Mar 2026 Direct
Keith D. Taylor EQIX Common Stock Sale -2.78% $730,504 $961.19 -760 26,587 12 Mar 2026 Direct
Kurt Pletcher EQIX Common Stock Sale -12% $539,819 $965.69 -559 4,109 12 Mar 2026 Direct
Michael Shane Paladin EQIX Common Stock Sale -4.59% $114,067 $966.67 -118 2,450 12 Mar 2026 Direct
Simon Miller EQIX Common Stock Sale -3.66% $279,096 $965.73 -289 7,615 12 Mar 2026 Direct
Charles J. Meyers EQIX Common Stock Sale -2.36% $293,163 $961.19 -305 12,594 12 Mar 2026 Direct
Jonathan Lin EQIX Common Stock Sale -5.56% $613,227 $965.71 -635 10,788 12 Mar 2026 Direct
Brandi Galvin Morandi EQIX Common Stock Sale -5.71% $605,550 $961.19 -630 10,394 12 Mar 2026 Direct
Adaire Fox-Martin EQIX Common Stock Sale -5.26% $1,049,295 $966.20 -1,086 19,574 12 Mar 2026 Direct
Raouf Abdel EQIX Common Stock Sale -6.99% $563,961 $965.69 -584 7,768 12 Mar 2026 Direct
Keith D. Taylor EQIX Common Stock Options Exercise 2.86% 760 27,347 11 Mar 2026 Direct
Keith D. Taylor EQIX Restricted Stock Unit Options Exercise -100% -760 0 11 Mar 2026 Direct
Keith D. Taylor EQIX Restricted Stock Unit Award 760 760 11 Mar 2026 Direct
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .